 Sienna Biopharmaceuticals, Inc., a Westlake Village, Calif.-based clinical stage medical dermatology and aesthetics company, completed a 40m Series B financing. The round was led by existing investors ARCH Venture Partners and Venvest Capital with participation from Partner Fund Management, Altitude Life Science Ventures, and Dr. David Pyott and new investors Fidelity Management Research Company, ... 